help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2007-1194
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vila, G.
Right arrow Articles by Clodi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vila, G.
Right arrow Articles by Clodi, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 10 3930-3934
Copyright © 2007 by The Endocrine Society

Bacterial Endotoxin Induces Biphasic Changes in Plasma Ghrelin in Healthy Humans

Greisa Vila, Christina Maier, Michaela Riedl, Peter Nowotny, Bernhard Ludvik, Anton Luger and Martin Clodi

Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, A-1090, Vienna, Austria

Address all correspondence and requests for reprints to: Martin Clodi, Department of Medicine III, Medical University of Vienna, Waehringer Guertel 18–20, A-1090, Vienna, Austria. E-mail: martin.clodi{at}meduniwien.ac.at.

Context: Ghrelin is a gut hormone with a highly preserved biological activity, which seems not to be restricted to the regulation of food intake, body composition, and growth. Continuous research is unraveling new properties of ghrelin, among others cardiovascular and antiinflammatory activities. Ghrelin is recently implicated in the host response to bacterial endotoxin in rodents and suggested as a possible therapeutic tool in sepsis.

Objective: This study aimed to investigate plasma ghrelin levels during human bacterial endotoxemia.

Design and Setting: We conducted a randomized, placebocontrolled, crossover clinical trial at a university medical center.

Study Participants: Participants included 10 healthy men.

Intervention: After an overnight fast, study subjects were randomized to 2 ng/kg Escherichia coli endotoxin [lipopolysaccharide (LPS)] or placebo and monitored for 6 h.

Main Outcome Measures: We measured ghrelin, GH, ACTH, cortisol, glucose, free fatty acids, TNF-{alpha}, IL-6, and IL-1 receptor antagonist.

Results: LPS administration induced a rapid ghrelin surge at 120 min ({Delta} ghrelin 100.2 ± 30.3 vs. 7.2 ± 26.4 pg/ml on the placebo day, P = 0.042). This ghrelin peak occurred 30 min after the TNF-{alpha} peak and corresponded with IL-6, GH, and ACTH peaks. Starting from 120 min and thereafter, ghrelin continuously decreased, reaching a nadir at 5 h after LPS administration ({Delta} ghrelin, –43.8 ± 28.4 compared with 70.3 ± 38.2 pg/ml on the control days, P = 0.038).

Conclusions: Ghrelin is one of the first hormones rapidly increasing in the human physiological response to bacterial endotoxic shock. Plasma ghrelin might be part of the complex immuno-neuroendocrine mechanisms activated by systemic infection and inflammation in humans.




This article has been cited by other articles:


Home page
J EndocrinolHome page
G. Vila, M. Riedl, M. Resl, A. J. van der Lely, L. J Hofland, M. Clodi, and A. Luger
Systemic administration of oxytocin reduces basal and lipopolysaccharide-induced ghrelin levels in healthy men
J. Endocrinol., October 1, 2009; 203(1): 175 - 179.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Moller and J. O. L. Jorgensen
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Endocr. Rev., April 1, 2009; 30(2): 152 - 177.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. Vila, M. Resl, D. Stelzeneder, J. Struck, C. Maier, M. Riedl, M. Hulsmann, R. Pacher, A. Luger, and M. Clodi
Plasma NT-proBNP increases in response to LPS administration in healthy men
J Appl Physiol, December 1, 2008; 105(6): 1741 - 1745.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society